Development of Topical Diclofenac Sodium Liposomal Gel for Better Antiinflammatory Activity

DOI:

https://doi.org/10.37285/ijpsn.2010.3.2.12

Authors

  • A V Jithan
  • Swathi M

Abstract

The objective of this study was to develop a diclofenac liposomal gel intended for better anti-inflammatory activity compared to a normal gel after topical administration. Spherical multilamellar vesicular liposomes (MLVs) consisting of soya lecithin, cholesterol and diclofenac were prepared via thin film hydration methodology. Small unilamellar vesicles (SUVs) were then prepared out of MLVs. Entrapment efficiency, the drug associated with SUVs was subsequently determined. Liposomal gel formulations were then prepared by incorporation of SUVs into carbopol 934 gel previously prepared. The formulations were then characterized for in vitro drug release, ex vivo permeation studies, drug-lipid compatibility and rheological behaviour. Vesicle size/Zeta potential of the liposomes containing in one selected formulation were determined. Pharmacodynamics was also determined for selected diclofenac liposomal gel. Diclofenac liposomal gel formulation prepared showed more sustained and prolonged anti-inflammatory effect compared with diclofenac gel. Taken together, the results indicate that the diclofenac liposomal gel is better than the regular gel without liposomes. Drug-lipid compatibility studies indicated no interaction with drug and the polymer.  

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Liposomes, Liposomal gel, Diclofenac, Transdermal delivery, Anti-inflammatory activity

Downloads

Published

2010-08-31

How to Cite

1.
Jithan AV, M S. Development of Topical Diclofenac Sodium Liposomal Gel for Better Antiinflammatory Activity. Scopus Indexed [Internet]. 2010 Aug. 31 [cited 2024 Dec. 23];3(2):986-93. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/505

Issue

Section

Research Articles

References

Barry BW. Novel mechanisms and devices to enable successful transdermal drug Delivery. Eur J Pharm Sci. 14: 101–14(2001).

Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev. 56: 675–711 (2004).

El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: From drug delivery to model membranes. Eur J pharm sci. 34: 203–22(2008).

Grace J.Lim, Yozo Ishiuji, Aerlyn Dawn, Benjamin Harrison, Do won Kim, Anthony Atala, Gil Yosopovithch. In vitro and In vivo Characterization of a Novel Liposomal Butorphanol Formulation for Treatment of Pruritus. Acta Derm Venereol. 88: 327–330 (2008).

Esposito E, Zanella C, Cortesi R, Menegatti E, Nastruzzi C. Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate. Int J Pharm. 172: 255–60 (1998).

Shan-shan, Qing Du, De-Ying Cao.Preparation of liposomal fluconazole gel and invitro transdermal delivery. J Chinese Pharma Sci. 16:116-118 (2007).

Zeljka Pavelic, Natasa Skalko-Basnet, Rolf Schubert. Liposomal gels for vaginal drug delivery, Int J Pharm. 19: 139-149 (2001).

Zeljka Pavelc, Natasa Skalko Basnet, Ivan Jalsenjak. Liposomal gel with chloramphenicol: Characterisation and in vitro release. Acta Pharm. 54: 319–330 (2004).

Beukelman CJ, van den Berg AJJ, Hoekstra MJ, Uhl R, Reimer K, Mueller S. Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel®) for wound healing in vitro, Burns. 34: 845-55 (2008).

Chuasuwan B, Binjesoh V, Polli JE, Zhang H, Amidon GL, Junginger HE, Midha KK, Shah VP, Stavchansky S,. Dressman JB, Barends DM. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Diclofenac Sodium and Diclofenac Potassium. J Pharm Sci. 98: 12-15 (2009).

Amnon Sintov C, Shafir Botner. Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm. 311: 55–62(2006).

Manosroi, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 360: 156– 63 (2008).

Zeljka Pavelic, Natasa Skalko-Basnet, Jelena Filipovic-Grcic, AnitaMaetinac, Ivan Jalsenjak. Development and invitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release. 106: 34-43 (2005).

Gande Suresh, Kopparam Manjunath, Vobalaboina Venkateswarlu, Vemula Satyanarayana. Preparation, Characterization and In Vitro and In Vivo Evaluation of Lovastatin Solid Lipid Nanoparticles. AAPS Pharm Sci Tech. 8: 12-16 (2007).

Kesavan Bhaskar, Jayaraman Anbu, Velayutham Ravichandiran, Vobalaboina of Venkateswarlu, Yamsani Madhusudan Rao. Lipid nanoparticles for transdermal delivery flurbiprofen: formulation, in vitro, ex vivo and in vivo studies; Lipids in health and Disease. 8: 6 (2009)

Nina Dragicevic-Curic, Sven Winter, Mirjana Stupar, Jela Milic, Danina Krajisnik, Burkhard Gitter, Alfred Fahr. Temoporfin-loaded liposomal gels: Viscoelastic properties and in vitro skin penetration. Int J Pharm. 373: 77–84 (2009).

Faiyaz Shakeel, Sanjula Baboota, Alka Ahuja, Javed Ali, Mohammed Aqil, Sheikh Shafiq. Nanoemulsions as Vehicles for Transdermal Delivery of Acefclofenac. AAPS PharmSciTech. 8: 14-20(2007).

Perez Grm. Anti-inflammatory activity of Ambrosia artemisiaefolia and Rheo spathacea. Phytomed. 3: 163-167(1996).